Serplulimab trials for Breast cancer

All Serplulimab trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Serplulimab for Breast cancer

• NabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer.
  NCT06781281 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Neoadjuvant Serplulimab Plus Weekly Paclitaxel and Carboplatin in TNBC (Neo-SERPENT)
  NCT07283692 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Serplulimab Combined With Chemotherapy for Early-stage HR+/HER2- Breast Cancer
  NCT06860529 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Serplulimab for Breast cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.